The EPIVAC Group (Epidemiology and Vaccines), accredited as a consolidated research group in the call SGR 2013 and reaccredited SGR 2017, conducts epidemiological and clinical research in vaccine-preventable infectious diseases of the respiratory system, especially cohort studies evaluating the effectiveness in practice of pneumococcal and influenza vaccinations from primary care. During 2017-2022 the group has carried out 3 research projects funded in competitive public calls (ISCIII and PERIS). The members of the group have directed 2 doctoral theses and have published (as first authors) more than 15 scientific articles in national and international biomedical journals, with a bibliometric impact factor exceeding 30 points. Some of the group’s papers have been incorporated into the most recent updates of Cochrane reviews on the subject and have been used to establish recommendations in various clinical practice guidelines.
